<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FNS</journal-id><journal-title-group><journal-title>Food and Nutrition Sciences</journal-title></journal-title-group><issn pub-type="epub">2157-944X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fns.2020.1111073</article-id><article-id pub-id-type="publisher-id">FNS-104502</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Effect of a Diet Rich in Interesterified, Non-Interesterified and Trans Fats on Biochemical Parameters and Oxidative Status of Balb-c Mice
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elinete</surname><given-names>Eliete de Lima</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Luiza</surname><given-names>S. E. P. W. Castro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Valdelúcia</surname><given-names>Maria A. de S. Grinevicius</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Josiane</surname><given-names>Hilbig</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nádia</surname><given-names>S. R. S. Mota</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rodrigo</surname><given-names>C. Zeferino</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Roberta</surname><given-names>C. da Silva</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Iván</surname><given-names>Jachmanián</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edson</surname><given-names>Luiz da Silva</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rozangela</surname><given-names>C. Pedrosa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jane</surname><given-names>Mara Block</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Laboratory of Fats and Oils, Department of Food Science and Technology, Federal University of Santa Catarina, Florianópolis, SC, Brazil</addr-line></aff><aff id="aff1"><addr-line>Campus Florianópolis Continente, Federal Institute of Education, Science and Technology of Santa Catarina, Florianópolis-SC, Brazil</addr-line></aff><aff id="aff4"><addr-line>Faculty of Pharmaceutical Sciences, University of S&amp;amp;#227;o Paulo, S&amp;amp;#227;o Paulo-SP, Brazil</addr-line></aff><aff id="aff2"><addr-line>Laboratory of Experimental Biochemistry, Department of Biochemistry, Federal University of Santa Catarina, Florianópolis, SC, Brazil</addr-line></aff><aff id="aff6"><addr-line>Laboratory of Lipids, Department of Clinical Analysis, Federal University of Santa Catarina, Florianópolis-SC, Brazil</addr-line></aff><aff id="aff5"><addr-line>Department of Food Science and Technology, Facultad de Química, Universidad de la República, Montevideo, Uruguay</addr-line></aff><pub-date pub-type="epub"><day>12</day><month>11</month><year>2020</year></pub-date><volume>11</volume><issue>11</issue><fpage>1032</fpage><lpage>1052</lpage><history><date date-type="received"><day>3,</day>	<month>October</month>	<year>2020</year></date><date date-type="rev-recd"><day>27,</day>	<month>November</month>	<year>2020</year>	</date><date date-type="accepted"><day>30,</day>	<month>November</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The aim of this study was
   to investigate the effects of different modified fats on the body weight, biochemical profile, and biomarkers of hepatic oxidative status in Balb-
  &lt;i&gt;
  c
  &lt;/i&gt;
   
  mice. The animals were divided into four groups and fed for 75 days with a normolipidic (Control Group
  ,
   CG) or hiperlipidic diets (40% kcal) containing a commercial interesterified fat (IFG) rich in palmitic acid (39%); a blend of non-interesterified fat (NIFG), with 2-fold less saturated fatty acids at the 
  &lt;i&gt;
  sn
  &lt;/i&gt;
  -2 position of triacylglycerols; or a partially hydrogenated vegetable oil (PHFG), source of trans fatty acid (20%) and of linolenic acid (6%). The mice of the IFG and NIFG presented similar results in all evaluated parameters. The serum biochemical profile and hepatic oxidative stress markers in mice of the PHFG were similar to CG, except for total cholesterol (TC) which was significantly higher (p &lt; 0.05) for the mice of the PHFG. The mice feed with interesterified fat (IFG) showed serum TC (p &lt; 0.01), non-HDL-C (p &lt; 0.05), glucose (p &lt; 0.05) and hepatic reduced glutathione values (2.7 fold, p &lt; 0.05) and glutathione reductase activity (2.4 fold, p &lt; 0.001) significantly higher when compared to the mice fed with partially hydrogenated vegetable oil (PHFG). The hydrogenated fat source of trans fatty acid (20%) had less important metabolic effects than fats containing amount
  s
   of palmitic acid (interesterified or non-interesterified). Our results suggest that the replacement of hydrogenated fats by interesterified fats may not be such a simple solution to reduce or eliminate 
  &lt;i&gt;
  trans
  &lt;/i&gt;
   fatty acids in foods.
 
</p></abstract><kwd-group><kwd>Interesterified Fat</kwd><kwd> &lt;i&gt;Trans&lt;/i&gt; Fat</kwd><kwd> Palmitic Acid</kwd><kwd> Cholesterol</kwd><kwd> Oxidative Stress</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The interesterification has been primarily used to replace the hydrogenation by the food industry as an economically viable alternative. The process allows the production of zero-trans fats with desirable functional properties. The triacylglycerol composition of blends of fats and oil is modified by rearranging the fatty acids within and between triglyceride molecules, using chemical or enzymatic catalysis [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>].</p><p>The interesterified fats commonly used in the food industry contain fats that are rich in long-chain SFA, such as palmitic acid (16:0) and stearic acid (18:0) [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref11">11</xref>]. A proper melt profile and solid fat content can be achieved using palm oil, which presents 50% of saturated fat in its composition [<xref ref-type="bibr" rid="scirp.104502-ref12">12</xref>]. In addition, unlike unmodified vegetable oils, interesterified fats have a larger amount of saturated fatty acids (SFA) at the sn-2 position of glycerol. The effect of the specific arrangement of the fatty acids on the glycerol backbone on health is not understood. There is a possibility that positional composition may affect dietary fat metabolism, digestibility and consequent effects on cardiovascular health [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref11">11</xref>].</p><p>The role of interesterified fat on metabolism has been reported in previous studies [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>]. In a recent systematic review, the interesterification of palmitic or stearic acid-rich fats does not seem to affect fasting serum lipids and (apo) lipoproteins [<xref ref-type="bibr" rid="scirp.104502-ref13">13</xref>]. Other research suggests effects of the consumption of interesterified fat on lipoprotein metabolism, glycemic control, and serum liver enzymes [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref14">14</xref>]. The nutritional and health implications of the long-term consumption of interesterified fat need to be better understood [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>]. In addition, most studies used fats that are not commercially relevant [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref11">11</xref>]. For instance, interesterified oils containing groundnut oil with linseed oil [<xref ref-type="bibr" rid="scirp.104502-ref15">15</xref>], and palm oil with rice bran oil [<xref ref-type="bibr" rid="scirp.104502-ref16">16</xref>]. Therefore, there is need for studies that investigate the nutritional and health effects of long-term intake of commercially available interesterified fats.</p><p>The objective of this study was to investigate the effects of supplementation of 1) a commercial interesterified fat rich in SFA, mainly located at the sn-2 position of the TAG backbone; 2) a blend with the same FA composition as the Interesfied Fat (IF), but with a lower amount of SFA at position sn-2 and; 3) a partially hydrogenated vegetable oil source of TFA, on the nutritional and biochemical profile and hepatic oxidative stress markers in Balb-c mice.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Fats</title><p>Commercial interesterified (IF) and non-interesterified fats (NIF) were obtained from the Ind&#250;stria Tri&#226;ngulo Alimentos Ltda (S&#227;o Paulo, Brazil). The IF was produced by chemical interesterification for the bakery application. The IF and NIF presented the same fatty acid profile since they were composed of the same oils and fats (palm oil, palm stearin, and fully hydrogenated soybean oil). Partially hydrogenated fat (PHF) was purchased in a local supermarket, and it was formulated with a mixture of soybean and palm oil.</p></sec><sec id="s2_2"><title>2.2. Fatty Acid Profile of Fats</title><p>The Fatty Acids Methyl Esters (FAMEs) were obtained using the methodology described by O’Fallon et al. [<xref ref-type="bibr" rid="scirp.104502-ref17">17</xref>]. Analyses were carried out by gas chromatography (GC-2014, Shimadzu, Kyoto, Japan) using a capillary column RTX&#174; 2330 (105 m &#215; 0.25 mm ID; 0.20 μm film thickness) containing 90% biscyanopropyl and 10% phenylcyanopropyl polysiloxane (Restek&#174;, Bellefont, USA). The column flow was 1.0 mL∙min<sup>−1</sup> with injected volume (1.0 μL) using a split ratio of 1:40. Synthetic air was the carrier gas, and nitrogen was the makeup gas. The temperature of the column injector was 250˚C. The column heating ramp started at 130˚C and was kept for 5 min, and then increased to 180˚C, with an increased rate of 5˚C min<sup>−1</sup>. Afterward, the column was held at 180˚C during 10 min. Then, after increasing temperature from 180˚C to 240˚C (increase rate of 3˚C∙min<sup>−1</sup>), the column temperature was held at 240˚C for 13 min. The flame ionization detector (FID) temperature was kept at 260˚C. The FAMEs were identified and quantified as percentages (%) based on their retention times and peak areas compared to the fatty acid’s standards.</p></sec><sec id="s2_3"><title>2.3. Regiospecific Distribution of Fatty Acids in Triacylglycerols</title><p>The regiospecific distribution of fatty acids was carried out according to Vlahov [<xref ref-type="bibr" rid="scirp.104502-ref18">18</xref>] using a Bruker Advance DPX 300 spectrometer (S&#227;o Paulo, Brazil), performed with multinuclear probe (5 mm) operating at 30˚C at a constant frequency (75.8 MHz).</p></sec><sec id="s2_4"><title>2.4. Triacylglycerol Composition of Fat</title><p>The triacylglycerol composition of the fats was determined according to Segura et al. [<xref ref-type="bibr" rid="scirp.104502-ref19">19</xref>] using an HPLC Shimadzu Prominence 20A (Kyoto, Japan) coupled with an evaporative light scattering detector (ELSD-LTII Shimadzu) with two serial columns (Supelcosil™ C18; 25 cm &#215; 4.6 mm &#215; 5 μm) operating at 20˚C. Each sample (5 mg) was firstly dissolved in acetone (1 mL) and then injected (1 μL) using acetone/acetonitrile (1:1; v/v) as mobile phase with a constant flow rate (1 mL∙min<sup>−1</sup>). Additionally, a chloroform gradient (0% to 20%) was applied for 60 min. Then, this condition was kept for 20 min. The order of elution of triacylglycerols standards and its corresponding equivalent carbon number (ECN) was used to identify each triacylglycerols peak in the sample.</p></sec><sec id="s2_5"><title>2.5. In Vivo Study</title><sec id="s2_5_1"><title>2.5.1. Animals and Experimental Design</title><p>Twenty four female Balb-c mice (60 days old; 20.0 &#177; 1.0 g body weight) were household under controlled environmental conditions (photoperiod 12 h; temperature 21˚C &#177; 1˚C and air humidity 53% &#177; 2%). Mice were kept in plastic cages (maximum 6 animals/cage) receiving water and commercial or formulated pelleted chow ad libidum. Animal maintenance and treatments followed the protocol approved by the Ethics Committee for Animals Use (CEUA/UFSC PPOO784) and in agreement with the National Institutes of Health (NIH) Guidelines.</p><p>Animals were randomly assigned to one of four experimental groups (n = 6 for each group): control group (CG); interesterified fat group (IFG); non-interesterified fat group (NIFG), and partially hydrogenated fat group (PHFG). The CG received commercial chow Bio Tec Rats and Mice, manufactured by Bio Base&#174; Company (&#193;guas Frias, Brazil), composed of ground corn, soy bran, wheat bran, degummed soy oil, mixture of vitamins, mixture of mineral salts, adsorbent additive, antifungal additive and antioxidant additive. The other groups received the same feed enriched with the specific fats (interesterified fat, non-interesterified fat, or partially hydrogenated fat). The hyperlipids and isocaloric formulations were prepared by adding proper amounts of specific fats in the standard chow. <xref ref-type="table" rid="table1">Table 1</xref> presents the ingredients, composition (Kcal%) and energy value of the</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Ingredients, composition and energy value (Kcal %) of the experimental diets: Control Group (CG); Interesterified Fat Group (IFG); Non-interesterified Fat Group (NIFG), and Partially Hydrogenated Fat Group (PHFG)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Ingredients (g/kg of diet)</th><th align="center" valign="middle" >Normolipid diet</th><th align="center" valign="middle"  colspan="3"  >Hyperlipids diets</th></tr></thead><tr><td align="center" valign="middle" >CG</td><td align="center" valign="middle" >IFG</td><td align="center" valign="middle" >NIFG</td><td align="center" valign="middle" >PHFG</td></tr><tr><td align="center" valign="middle" >Commercial chow Bio Tec Rats and Mice<sup>1</sup></td><td align="center" valign="middle" >1000</td><td align="center" valign="middle" >833</td><td align="center" valign="middle" >833</td><td align="center" valign="middle" >833</td></tr><tr><td align="center" valign="middle" >Interesterified fat<sup>2</sup></td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >167</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Non-interesterified fat<sup>3</sup></td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >167</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Partially hydrogenated vegetable fat<sup>4</sup></td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >167</td></tr><tr><td align="center" valign="middle" >Composition (Kcal %)/ Energy value (kJ/g and kcal/g)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Lipids</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Proteins</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Carbohydrates</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Energy</td><td align="center" valign="middle" >15.06 kJ (3.6 kcal)</td><td align="center" valign="middle" >22.6 kJ (5.4 kcal)</td><td align="center" valign="middle" >22.6 kJ (5.4 kcal)</td><td align="center" valign="middle" >22.6 kJ (5.4 kcal)</td></tr></tbody></table></table-wrap><p>experimental diets. The formulations were pelletized according to a previous report [<xref ref-type="bibr" rid="scirp.104502-ref20">20</xref>], and the pellets were frozen at −18˚C. Small amounts of the chows were periodically thawed before feeding the mice during 75 days. Mice were weighed weekly, and food intake was estimated as the difference between the food offered and the residual food in the cages. The nutrition efficiency was expressed as a result of the rate between weight gain (g) and energy consumption (Kcal).</p></sec><sec id="s2_5_2"><title>2.5.2. Serum Biochemical Profile</title><p>After 75 days of treatment, all mice received anesthesia, and blood samples were collected through a cardiac puncture after 8-h fasting. Recovered serum (3000 rpm/10 min) was used for quantifying the lipids, lipoproteins, glucose, and transaminases. Triglycerides and total cholesterol were measured using the Tinder’s reaction [<xref ref-type="bibr" rid="scirp.104502-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref22">22</xref>]. HDL-C was determined by the homogeneous direct method [<xref ref-type="bibr" rid="scirp.104502-ref23">23</xref>] with a commercial colorimetric kit (LABTEST&#174;, Lagoa Santa City, Brazil). The non-HDL-C levels were estimated by the difference between total and HDL-C. Serum glucose was measured with a colorimetric, enzymatic method [<xref ref-type="bibr" rid="scirp.104502-ref24">24</xref>] (LABTEST&#174;). All measurements were performed using multiwell plate readings with TECAN Infinity M200&#174;. The activities of serum transaminases enzymes, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were measured by kinetic method at 340 nm, using commercial kits LABTEST&#174; [<xref ref-type="bibr" rid="scirp.104502-ref25">25</xref>].</p></sec><sec id="s2_5_3"><title>2.5.3. Hepatic Status Oxidative</title><p>At the end of the treatment, the animals were euthanized by cervical dislocation. Livers were rapidly removed, kept on ice, and perfused with ice saline solution (0.9% NaCl) for 5 min. A portion of 100 mg of liver was removed and immediately homogenized (1:9 w/v) in 0.1% Triton X-100, 0.12 M NaCl, 30 mM Na-phosphate buffer, pH 7.4. For the measurement of GSH content, TCA 12% was used. Homogenization was carried out at 4˚C in a Teflon piston homogenizer Tecnal&#174; (Campinas, Brazil), followed by centrifugation at 10,000 g for 10 min. The supernatant was used for the measurement of antioxidant defense (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase activities, and reduced glutathione, GSH content) and also oxidative stress markers lipid peroxidation (thiobarbituric acid-reactive substances, TBARS) and protein carbonyl content.</p><p>Superoxide dismutase (SOD) activity was measured by monitoring the oxidation of adrenaline to adrenochrome, as described by Misra and Fridovich [<xref ref-type="bibr" rid="scirp.104502-ref26">26</xref>]. Catalase (CAT) activity was measured indirectly through the decomposition of hydrogen peroxide monitored at 240 nm, according to Aebi [<xref ref-type="bibr" rid="scirp.104502-ref27">27</xref>]. Glutathione peroxidase (GPx) activity was measured at 340 nm, through the glutathione/ NADPH/glutathione reductase system, by the reduction of terc-butylhydroperoxide, as described by Floh&#233; and G&#252;nzler [<xref ref-type="bibr" rid="scirp.104502-ref28">28</xref>]. Glutathione reductase (GR) activity was determined through the NADPH oxidation rate measured at 340 nm, according to Carberg and Mannervik [<xref ref-type="bibr" rid="scirp.104502-ref29">29</xref>]. Reduced glutathione (GSH) content was directly proportional to the reaction between dithiobisnitrobenzoic acid (DTNB) and GSH thiol groups in the liver samples. The yellowish thiolate formed was determined spectrophotometrically at 412 nm, as described by Beutler et al. [<xref ref-type="bibr" rid="scirp.104502-ref30">30</xref>]. Enzyme activities and reduced GSH content results were normalized by the protein content using the Lowry method [<xref ref-type="bibr" rid="scirp.104502-ref31">31</xref>].</p><p>Evaluation of oxidative damage to lipids was determined through measurements of TBARS, according to Bird and Draper [<xref ref-type="bibr" rid="scirp.104502-ref32">32</xref>]. The oxidative damages related to protein carbonylation levels were determined spectrophotometrically at 340 nm, as described by Levine et al. [<xref ref-type="bibr" rid="scirp.104502-ref33">33</xref>]. All measurements were done using multiwell plate reader (TECAN Infinity M200&#174;).</p></sec></sec><sec id="s2_6"><title>2.6. Statistical Analysis</title><p>All assays were done in triplicate, and results were expressed as mean &#177; standard deviation. Data were analyzed by the one-way ANOVA test, followed by the Bonferroni test. Comparisons were made using GraphPad Prism software version 6.0 (San Diego, USA). Values of p &lt; 0.05 were considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Fatty acid Composition, Regiospecific Distribution of Fats, and Triacylglycerol Composition of Fat</title><p><xref ref-type="table" rid="table2">Table 2</xref> shows the fatty acid composition and the regiospecific distribution of</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Fatty acid composition of fats (g/100) and regiospecific distribution of fatty acids in sn-1,3 and sn-2 positions in triacylglycerols of Interesterified Fat (IF), Non-interesterified Fat (NIF) and Partially Hydrogenated Fat (PHF)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Fatty Acids</th><th align="center" valign="middle" >IF</th><th align="center" valign="middle" >NIF</th><th align="center" valign="middle" >PHF</th></tr></thead><tr><td align="center" valign="middle" >Lauric acid (C 12:0)</td><td align="center" valign="middle" >2.05 &#177; 0.21<sup>a</sup></td><td align="center" valign="middle" >1.95 &#177; 0.21<sup>a</sup></td><td align="center" valign="middle" >0.20 &#177; 0.00<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Myristic acid (C 14:0)</td><td align="center" valign="middle" >1.45 &#177; 0.07<sup>a</sup></td><td align="center" valign="middle" >1.25 &#177; 0.07<sup>a</sup></td><td align="center" valign="middle" >0.20 &#177; 0.00<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Palmitic acid (C 16:0)</td><td align="center" valign="middle" >39.10 &#177; 0.42<sup>a</sup></td><td align="center" valign="middle" >38.90 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >11.65 &#177; 0.21<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Stearic acid (C 18:0)</td><td align="center" valign="middle" >15.10 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >15.25 &#177; 0.35<sup>a</sup></td><td align="center" valign="middle" >13.25 &#177; 0.49<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Oleic acid (C18:1 n9c)</td><td align="center" valign="middle" >33.2 &#177; 0.71<sup>a</sup></td><td align="center" valign="middle" >33.55 &#177; 0.64<sup>a</sup></td><td align="center" valign="middle" >40.70 &#177; 0.14<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Linoleic acid (C 18:2 n6c)</td><td align="center" valign="middle" >8.15 &#177; 0.21<sup>a</sup></td><td align="center" valign="middle" >8.00 &#177; 0.00<sup>a</sup></td><td align="center" valign="middle" >8.05 &#177; 0.07<sup>a</sup></td></tr><tr><td align="center" valign="middle" >Linolenic acid (C 18:3 n3c)</td><td align="center" valign="middle" >0.20 &#177; 0.28<sup>a</sup></td><td align="center" valign="middle" >0.20 &#177; 0.28<sup>a</sup></td><td align="center" valign="middle" >5.60 &#177; 0.85<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Elaidic acid (C18:1 n9t)</td><td align="center" valign="middle" >0.10 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >0.10 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >17.00 &#177; 0.57<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Linolelaidic acid (C 18:2 n6t)</td><td align="center" valign="middle" >0.00 &#177; 0.00<sup>a</sup></td><td align="center" valign="middle" >0.00 &#177; 0.00<sup>a</sup></td><td align="center" valign="middle" >2.89 &#177; 0.69<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >0.65&#177; 0.78<sup>a</sup></td><td align="center" valign="middle" >0.80&#177; 0.00<sup>a</sup></td><td align="center" valign="middle" >0.46&#177; 0.08<sup>a</sup></td></tr><tr><td align="center" valign="middle" >Total SFA</td><td align="center" valign="middle" >57.70 &#177; 0.0<sup>a</sup></td><td align="center" valign="middle" >57.35 &#177; 0.49<sup>a</sup></td><td align="center" valign="middle" >25.30 &#177; 0.28<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Total MUFA</td><td align="center" valign="middle" >33.20 &#177; 0.71<sup>a</sup></td><td align="center" valign="middle" >33.55 &#177; 0.64<sup>a</sup></td><td align="center" valign="middle" >40.70 &#177; 0.14<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Total PUFA</td><td align="center" valign="middle" >8.35 &#177; 0.07<sup>a</sup></td><td align="center" valign="middle" >8.20 &#177; 0.28<sup>a</sup></td><td align="center" valign="middle" >13.65 &#177; 0.92<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Total TFA</td><td align="center" valign="middle" >0.10 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >0.10 &#177; 0.14<sup>a</sup></td><td align="center" valign="middle" >19.89 &#177; 1.26<sup>b</sup></td></tr><tr><td align="center" valign="middle" >Fatty acids position</td><td align="center" valign="middle" >IF</td><td align="center" valign="middle" >NIF</td><td align="center" valign="middle" >PHF</td></tr><tr><td align="center" valign="middle" >SFA (sn-1.3)</td><td align="center" valign="middle" >59.90</td><td align="center" valign="middle" >72.60</td><td align="center" valign="middle" >41.20</td></tr><tr><td align="center" valign="middle" >SFA (sn-2)</td><td align="center" valign="middle" >61.20</td><td align="center" valign="middle" >28.10</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >MUFA (sn-1.3)</td><td align="center" valign="middle" >31.20</td><td align="center" valign="middle" >20.40</td><td align="center" valign="middle" >52.00</td></tr><tr><td align="center" valign="middle" >MUFA (sn-2)</td><td align="center" valign="middle" >21.30</td><td align="center" valign="middle" >50.60</td><td align="center" valign="middle" >49.10</td></tr><tr><td align="center" valign="middle" >PUFA (sn-1.3)</td><td align="center" valign="middle" >8.90</td><td align="center" valign="middle" >7.00</td><td align="center" valign="middle" >6.80</td></tr><tr><td align="center" valign="middle" >PUFA (sn-2)</td><td align="center" valign="middle" >17.50</td><td align="center" valign="middle" >21.30</td><td align="center" valign="middle" >50.90</td></tr></tbody></table></table-wrap><p>SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids TFA: trans fatty acids. Mean &#177; S.D. (n = 2). Different letters at the same row mean statistical difference between experimental groups (p &lt; 0.05).</p><p>fatty acids in the sn-1,3 and sn-2 positions in triacylglycerols of IF, NIF, and PHF. The IF and NIF fats presented the same fatty acid profile, which was rich in SFA (especially palmitic acid) and TFA free. IF presented a higher amount of SFA at the sn-2 position of triacylglycerol (2-fold) when compared to NIF. On the other hand, PHF presented a higher concentration of oleic fatty acid and 20% of TFA (mainly elaidic acid), 6% of linolenic acid, and absence of SFA at sn-2 position. <xref ref-type="table" rid="table3">Table 3</xref> shows the effect of the interesterification on the triacylglycerols composition of IF and NIF fats. IF presented a lower amount of trisaturated (especially SSS) and disaturated triacylglycerols (especially PPO) and a higher amount (4-fold) of tri-unsaturated triacylglycerols (especially OOO), when compared to NIF.</p></sec><sec id="s3_2"><title>3.2. Food Intake, the Gain of Body Weight and Energy Consumption</title><p>A significant decrease in food consumption (p &lt; 0.001; <xref ref-type="fig" rid="fig1">Figure 1</xref>(A)) was observed</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Triacylglycerols (TAGs) composition of the interesterified fat (IF) and non-interesterified fat (NIF)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >TAGs Structure</th><th align="center" valign="middle" >ECN</th><th align="center" valign="middle" >IF (%)</th><th align="center" valign="middle" >NIF (%)</th></tr></thead><tr><td align="center" valign="middle" >PPP</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >4.72</td><td align="center" valign="middle" >4.30</td></tr><tr><td align="center" valign="middle" >PSS</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >1.64</td><td align="center" valign="middle" >2.90</td></tr><tr><td align="center" valign="middle" >SSS</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >15.20</td></tr><tr><td align="center" valign="middle" >Trisaturated</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >6.36</td><td align="center" valign="middle" >22.40</td></tr><tr><td align="center" valign="middle" >PPL</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >8.01</td><td align="center" valign="middle" >6.10</td></tr><tr><td align="center" valign="middle" >PPO</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >5.73</td><td align="center" valign="middle" >31.00</td></tr><tr><td align="center" valign="middle" >POS</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >13.70</td><td align="center" valign="middle" >1.60</td></tr><tr><td align="center" valign="middle" >SOS</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >1.60</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Disaturated</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >29.04</td><td align="center" valign="middle" >38.7</td></tr><tr><td align="center" valign="middle" >PLL</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >1.58</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >PLO</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >1.51</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >POO</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >19.19</td><td align="center" valign="middle" >22.80</td></tr><tr><td align="center" valign="middle" >SOO</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >7.35</td><td align="center" valign="middle" >4.20</td></tr><tr><td align="center" valign="middle" >Monosaturated</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >29.63</td><td align="center" valign="middle" >27.00</td></tr><tr><td align="center" valign="middle" >LLO</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >2.21</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >LOO</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >9.73</td><td align="center" valign="middle" >6.70</td></tr><tr><td align="center" valign="middle" >OOO</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >15.32</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Triunsaturated</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >27.26</td><td align="center" valign="middle" >6.70</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >7.71</td><td align="center" valign="middle" >5.20</td></tr></tbody></table></table-wrap><p>ECN = equivalent carbon number; O: oleic acid; L: linoleic acid; P: palmitic acid; S: stearic acid.</p><p>for the animals fed with the hyperlipid diets (IFG, NIFG, and PHFG) when compared to the control group (CG). The energy consumption was significantly higher for animals from the IFG, NIFG and PHFG (p &lt; 0.001; <xref ref-type="fig" rid="fig1">Figure 1</xref>(C)). On the other hand, it was not observed a significant difference in the body weight gain between all experimental groups (<xref ref-type="fig" rid="fig1">Figure 1</xref>(B)). <xref ref-type="fig" rid="fig2">Figure 2</xref> shows the weight gain for the animals of the experimental groups during 75 days. The nutrition efficiency (<xref ref-type="fig" rid="fig1">Figure 1</xref>(D)) also did not present differences between the groups. However, the animals of the hyperlipidic groups (IFG, NIFG and PHFG) presented fat deposition in the abdomen (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Serum Biochemical Profile</title><p>The serum triglycerides were not affected by the fat present in the diet of the animals (<xref ref-type="fig" rid="fig4">Figure 4</xref>(A)). On the other hand, the TC (<xref ref-type="fig" rid="fig4">Figure 4</xref>(B)) increased in the Balb-c mice fed with the hyperlipidic diets, IFG and NIFG (p &lt; 0.001), and PHFG (p &lt; 0.05) when compared to CG. The increase for IFG and NIFG was</p><p>more expressive and significant (p &lt; 0.01 and p &lt; 0.001, respectively) when compared to PHFG. The HDL-C levels were significantly higher (p &lt; 0.01) in the serum of the animals fed with IF and NIF when compared with CG (<xref ref-type="fig" rid="fig4">Figure 4</xref>(C)). On the other hand, no significant differences were observed between IFG, NIFG, and PHFG. <xref ref-type="fig" rid="fig4">Figure 4</xref>(D) shows that IFG and NIFG presented a significant increase for non-HDL-C when compared to CG (p &lt; 0.001) and to PHFG (p &lt; 0.05, p &lt; 0.001, respectively). <xref ref-type="fig" rid="fig4">Figure 4</xref>(E) shows that the serum levels of glucose were statistically higher for IFG when compared to PHFG (p &lt; 0.05). The serum enzymes of hepatic function AST and ALT (<xref ref-type="fig" rid="fig4">Figure 4</xref>(F) and <xref ref-type="fig" rid="fig4">Figure 4</xref>(G), respectively), did not change between the treatments.</p></sec><sec id="s3_4"><title>3.4. Oxidative Stress and Antioxidant Defense</title><p>The hepatic GSH content detected in the animals fed with IF and NIF was approximately 2.3 and 2.7 times higher when compared to CG and PHFG (p &lt; 0.05). On the other hand, the results for hepatic GSH content for the animals fed with PHF were similar to the animals of the CG (<xref ref-type="fig" rid="fig5">Figure 5</xref>(A)).</p><p>No differences were observed between the animals of the CG and those who received the diets studied for the oxidative markers, TBARS (<xref ref-type="fig" rid="fig5">Figure 5</xref>(B)), carbonyl protein values (<xref ref-type="fig" rid="fig5">Figure 5</xref>(C)) and for the antioxidant enzymes SOD (<xref ref-type="fig" rid="fig5">Figure 5</xref>(D)), CAT (<xref ref-type="fig" rid="fig5">Figure 5</xref>(E)), and GPx (<xref ref-type="fig" rid="fig5">Figure 5</xref>(G)). In contrast, an increase of approximately 3.5-fold in the GR activity (<xref ref-type="fig" rid="fig5">Figure 5</xref>(F)) was observed in the animals fed with IF and NIF compared to the CG. On the other hand, the GR activity in the animals fed with PHF was like those animals in the CG.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The FA analysis indicated that IF and NIF presented around 40% of palmitic acid (C16:0). These results were expected since one of the main raw materials used in interesterification processes is palm oil and palm stearin, which presents between 40% - 48% and 48% - 74% of palmitic acid, respectively [<xref ref-type="bibr" rid="scirp.104502-ref34">34</xref>]. On the other hand, the process of interesterification does not change the profile of FA of the interesterified fats [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>]. Vegetable oils that have not been modified typically exhibit the saturated fatty acid at the 1,3-position of the triacylglycerol [<xref ref-type="bibr" rid="scirp.104502-ref10">10</xref>]. In this study, was observed an increase of 100% of the amount of SFA at the sn-2 position. Soares et al. (2009) [<xref ref-type="bibr" rid="scirp.104502-ref35">35</xref>] reported similar results for a 60:40 mixture of stearin and palm olein.</p><p>The amount of TFAs found in the PHF (20%) was lower than the content reported for partially hydrogenated fats produced in the 1990s and early 2000 (from 30% to 60%) [<xref ref-type="bibr" rid="scirp.104502-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref37">37</xref>]. Mensink and Katan [<xref ref-type="bibr" rid="scirp.104502-ref2">2</xref>], in their classic study, reported an amount of 46% of TFAs in the margarine used in the experiments. The PHF also presented 6% of linolenic acid, which is an essential fatty acid. The presence of linolenic acid in the PHF indicates that this fat was produced with soybean oil, which contains 5.5% - 9.5% of this FA in its composition [<xref ref-type="bibr" rid="scirp.104502-ref34">34</xref>].</p><p>During the 75 days of treatments, the animals receiving the hyperlipidic diets (IFG, NIFG, and PHFG) presented lower food intake (p &lt; 0.001) and higher energy consumption (p &lt; 0.001). However, despite the lower dietary intake, the hyperlipidic diets increased the weight gain by about 40% (although not significant), similar to previously described, for mice Balb c [<xref ref-type="bibr" rid="scirp.104502-ref38">38</xref>].</p><p>The weight gain and visceral adipose tissue observed for the animals fed with the interesterified fat was not significant when compared to these parameters found in the animals fed with non-interesterified and trans diets. These results may be possibly related to the time of the experiment with the hyperlipidic diet. On the other hand, Gouk et al. [<xref ref-type="bibr" rid="scirp.104502-ref39">39</xref>] and Afonso et al. [<xref ref-type="bibr" rid="scirp.104502-ref40">40</xref>] reported greater weight gain in animals fed with interesterified fat after 15 and 16 weeks of treatment, respectively. Lavrador et al. [<xref ref-type="bibr" rid="scirp.104502-ref41">41</xref>] reported triggered adipocytes hypertrophy in LDLr-KO mice after 16 weeks of treatment com acid palmitic interesterified. Magri et al. and Velasco et al. [<xref ref-type="bibr" rid="scirp.104502-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref43">43</xref>] evaluated the weight gain and adiposity in C57BL/6 mice whose mothers received interesterified fat and partially hydrogenated fat during gestation and lactation. The authors concluded that the intake of interesterified and/or palm fats in this period might predispose the descendants to obesity in adult life. On the other hand, it was not observed for the group that received partially hydrogenated fat in the diet. Bispo et al. for C57BL-6 mice also reported that interesterified fat consumption led to deregulation in the expression of proteins involved in food intake [<xref ref-type="bibr" rid="scirp.104502-ref44">44</xref>].</p><p>The hyperlipidic diets used in this study did not change the serum levels of triglycerides. Controversial results have been reported in the literature for the levels of serum triglycerides after the consumption of interesterified fat. Ponnampalam et al. [<xref ref-type="bibr" rid="scirp.104502-ref45">45</xref>], in a study with piglets, reported an increase in the serum triglycerides after the consumption of enzymatically interesterified palm olein during 12 weeks. On the other hand, Reena; Lokeski (2007) and Sharma; Lokeski (2013) reported for Wistar rats a reduction of serum triglycerides after the consumption of interesterified fats composed of unsaturated oils during 60 days [<xref ref-type="bibr" rid="scirp.104502-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref46">46</xref>].</p><p>The IF and NIF diets increased significantly, the serum levels of total cholesterol, HDL-C, and non-HDL-C. These results indicate that the positional distribution of the palmitic acid in positions 1 and 3 does not alter the serum lipoproteins response. Similar results were reported in experiments with humans [<xref ref-type="bibr" rid="scirp.104502-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref11">11</xref>]. Berry [<xref ref-type="bibr" rid="scirp.104502-ref11">11</xref>] reported that triacylglycerols structure has no effect on either digestibility or fasting lipids. On the other hand, it has been reported for several authors that 20% of the energy in the diet as interesterified fat administered to Wistar rats, for 60 days, reduced total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels [<xref ref-type="bibr" rid="scirp.104502-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref47">47</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref48">48</xref>]. However, in these studies, blends composed of unsaturated oils, such as flaxseed, rice bran, sesame, peanut, and olive oil, were used. The fatty acid and triacylglycerol composition of these blends are very different from commercially available interesterified fats, which are rich in saturated FA, especially palmitic acid. The plasma lipid concentration of LDLr-KO mice fed for 16 weeks with interesterified fat (based on palm oil or totally hydrogenated canola oil and high-oleic sunflower oil); as 40% of the energy, was not changed [<xref ref-type="bibr" rid="scirp.104502-ref40">40</xref>]. However, the authors reported that interesterified fat rich in palmitic acid accelerated the development of atherosclerosis by promoting cholesterol accumulation in LDL particles and macrophage cells, activating the inflammatory process. The LDL, as well as other non-HDL-C (very low-density lipoprotein, VLDL; intermediate-density lipoprotein, IDL; lipoprotein (a), Lp(a); and chylomicron remnants), are related with the development of atherosclerosis [<xref ref-type="bibr" rid="scirp.104502-ref49">49</xref>]. Our results indicated that the increase in non-HDL-C in the serum of the animals who received fats rich in palmitic acid (IFG and NIFG) was higher than in animals fed with PHFG, a source of trans fat and linolenic acid. Although the trans-fat diet did not increase the non-HDL-C in the serum of the Balb-c mice, it is well-known that TFA consumption raises the non-HDL-C levels in the serum of humans [<xref ref-type="bibr" rid="scirp.104502-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref3">3</xref>]. Other studies have indicated that palmitic acid also increased total and LDL-cholesterol concentration [<xref ref-type="bibr" rid="scirp.104502-ref50">50</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref51">51</xref>], while linolenic acid may also contribute to the reduction of LDL-c [<xref ref-type="bibr" rid="scirp.104502-ref52">52</xref>]. Overall, these findings indicate that serum lipid response to IF, NIF, and trans-fat diet might be specie specific. Therefore, the results obtained using laboratory animals should be interpreted with caution.</p><p>In our study, no difference in serum glucose between the groups IFG and NIFG was observed. It has been reported for humans an increase the fasting plasma glucose and a decrease in plasma insulin [<xref ref-type="bibr" rid="scirp.104502-ref14">14</xref>] and in postprandial glucose-dependent insulinotropic polypeptide (GIP) concentrations after consumption of interesterified palm olein [<xref ref-type="bibr" rid="scirp.104502-ref53">53</xref>]. An increase in the levels of fasting glucose and impaired glucose tolerance was observed in Wistar rats after the consumption of interesterified soybean oil for 16 weeks. The same effect was not observed after 8 weeks [<xref ref-type="bibr" rid="scirp.104502-ref54">54</xref>]. In our study, a significant increase in serum glucose was observed in the animals fed with IF, compared to those fed with PHF. As reported by Miyamoto [<xref ref-type="bibr" rid="scirp.104502-ref54">54</xref>], the time of exposure to the diet with interesterified fat might be determinant for the increase of the plasma glucose. Lavrador et al. [<xref ref-type="bibr" rid="scirp.104502-ref41">41</xref>] also found no differences in glucose and insulin plasma concentrations in LDLr-KO mice fed a high-fat diet containing palmitic or interesterified palmitic fats for 16 weeks.</p><p>Hyperlipidic diets can lead to liver damage, including oxidative-based injuries [<xref ref-type="bibr" rid="scirp.104502-ref55">55</xref>]. In this study, after 75 days, the activities of the AST and ALT, main markers of hepatic function, were not affected. In LDLr-KO mice fed for 16 weeks which Interesterified fats enriched with palmitic or stearic acids was induced hepatic fibrosis, even without raising ALT levels [<xref ref-type="bibr" rid="scirp.104502-ref41">41</xref>]. Although the relationship between oxidative stress and the consumption of diets rich in TFAs is well-known [<xref ref-type="bibr" rid="scirp.104502-ref56">56</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref57">57</xref>], the trans-fat diet did not change the biomarkers values of oxidative stress in the Balb-c mice. Nagaraju; Lokeski [<xref ref-type="bibr" rid="scirp.104502-ref47">47</xref>] reported similar results for Wistar rats fed with IF and NIF diets.</p><p>A significant increase in the GSH and GR values was observed for the diets rich in palmitic acid. It has been shown that palmitic acid presented lipotoxicity in the liver cells [<xref ref-type="bibr" rid="scirp.104502-ref58">58</xref>] [<xref ref-type="bibr" rid="scirp.104502-ref59">59</xref>]. Therefore, the increased GR activity associated with an absence of oxidative stress markers induction might be responsible for the elevation of GSH levels in IFG and NIFG, indicating a potential protection against free radical-mediated damage in the liver. It is well known that the GSH redox system is important for decreasing oxidative stress. The GSH, a radical scavenger, is converted to oxidized glutathione (GSSG), and GR continuously converts GSSG back to GSH [<xref ref-type="bibr" rid="scirp.104502-ref60">60</xref>].</p><p>In addition, female mice are protected against metabolic changes caused by hyperlipidic diets, while maintaining an anti-inflammatory environment in the intra-abdominal adipose tissue with expanded Treg cell population, whereas male mice can develop adipose tissue inflammation, glucose intolerance, hyperinsulinemia, and islet hypertrophy [<xref ref-type="bibr" rid="scirp.104502-ref61">61</xref>]. Therefore, the metabolic changes caused by hyperlipidic diets could be even more visible if the study was conducted using male mice.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, the modification of the triacylglycerol structure, caused by interesterification, did not lead to different metabolic alterations. The mice that received the diet with interesterified fat presented similar results, as for the body weight gain, biochemical profile and biomarkers of hepatic oxidative stress, to the mice that received fat with the same fatty acid profile but with a lower (2-fold) amount of saturated fatty acids in the sn-2 position of triacylglycerol. However, the mice which received interesterified fat had higher serum total cholesterol, non-HDL-C and glucose concentrations, and different hepatic antioxidant response, than the group that received partially hydrogenated vegetable fat. Thus, in this study, a high-fat diet containing partially hydrogenated vegetable fat caused less important metabolic effects than fats rich in SFA and palmitic acid, interesterified, or non-interesterified. Our results suggest that the replacement of hydrogenated fats by interesterified fats may not be such a simple solution to reduce or eliminate trans fatty acids in foods, and it is necessary for further investigation in humans.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors are grateful to Tri&#226;ngulo Alimentos for the donation of interesterified fat and of blend of non-interesterified fat. J. M. Block thanks CNPq (Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico) for granting a scientific productivity fellowship (process 311070/2018-3).</p></sec><sec id="s7"><title>Funding</title><p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>None of the authors had a financial or personal conflict of interest.</p></sec><sec id="s9"><title>Cite this paper</title><p>de Lima, E.E., Castro, L.S.E.P.W., de S. Grinevicius, V.M.A., Hilbig, J., Mota, N.S.R.S., Zeferino, R.C., da Silva, R.C., Jachmani&#225;n, I., da Silva, E.L., Pedrosa, R.C. and Block, J.M. (2020) Effect of a Diet Rich in Interesterified, Non-Interesterified and Trans Fats on Biochemical Parameters and Oxidative Status of Balb-c Mice. Food and Nutrition Sciences, 11, 1032-1052. https://doi.org/10.4236/fns.2020.1111073</p></sec><sec id="s10"><title>Abbreviations</title><p>CG, control group;</p><p>IFG, interesterified fat group;</p><p>NIFG, non-interesterified group;</p><p>PHFG, partially hydrogenated vegetable fat group;</p><p>TC, total cholesterol;</p><p>Non-HDL-C, non-HDL cholesterol;</p><p>HDL, high density lipoproteins;</p><p>TFAs, trans fatty acids;</p><p>WHO, World Health Organization;</p><p>SFA, saturated fatty acids;</p><p>FA, fatty acids;</p><p>IF, interesfied fat;</p><p>NIF, non-interesterified;</p><p>PHF, partially hydrogenated vegetable fat;</p><p>FID, flame ionization detector;</p><p>FAMEs, fatty acids methyl esters;</p><p>ECN, equivalent carbon number;</p><p>NIH, National Institutes of Health;</p><p>AST, aspartate aminotransferase;</p><p>ALT, alanine aminotransferase;</p><p>SOD, superoxide dismutase;</p><p>CAT, catalase;</p><p>GPx, glutathione peroxidase;</p><p>GR, glutathione reductase;</p><p>GSH, reduced glutathione;</p><p>DTNB, dithiobisnitrobenzoic acid;</p><p>TBARS, thiobarbituric acid-reactive substances</p><p>TAGs, triacylglycerols;</p><p>SSS, trisaturated triacylglycerols (S, stearic acid);</p><p>PPO, disaturated triacylglycerols (P, palmitic acid and O, oleic acid)</p><p>OOO, tri-unsaturated triacylglycerols (O, oleic acid);</p><p>LDL-C, low-density lipoprotein cholesterol;</p><p>VLDL, very low-density lipoprotein;</p><p>IDL, intermediate-density lipoprotein;</p><p>Lp(a), lipoprotein (a);</p><p>GIP, insulinotropic polypeptide;</p><p>GSSG, oxidized glutathione.</p></sec><sec id="s11"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.104502-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mensink, R.P., Sanders, T.A., Baer, D.J., Hayes, K.C., Howles, P.N. and Marangoni, A. (2016) The Increasing Use of Interesterified Lipids in the Food Supply and Their Effects on Health Parameters. Advances in Nutrition, 7, 719-729. https://doi.org/10.3945/an.115.009662</mixed-citation></ref><ref id="scirp.104502-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mensink, R.P. and Katan, M.B. (1990) Effect of Dietary Trans Fatty Acids on High-Density and Low-Density Lipoprotein Cholesterol Levels in Healthy Subjects. The New England Journal of Medicine, 323, 439-445. https://doi.org/10.1056/NEJM199008163230703</mixed-citation></ref><ref id="scirp.104502-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Zock, P.L. and Mensink, R.P. (1996) Dietary Trans-Fatty Acids and Serum Lipoproteins in Humans. Current Opinion in Lipidology, 7, 34-37. https://doi.org/10.1097/00041433-199602000-00008</mixed-citation></ref><ref id="scirp.104502-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Itcho, K., Yoshii, Y., Ohno, H., Oki, K., Shinohara, M., Irino, Y., Toh, R., Ishida, T., Hirata, K.I. and Yoneda, M. (2017) Association between Serum Elaidic Acid Concentration and Insulin Resistance in Two Japanese Cohorts with Different Lifestyles. Journal of Atherosclerosis and Thrombosis, 24, 1206-1214. https://doi.org/10.5551/jat.39164</mixed-citation></ref><ref id="scirp.104502-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Liu, B., Sun, Y., Snetselaar, L.G., Sun, Q., Yang, Q., Zhang, Z., Liu, L., Hu, F.B. and Bao, W. (2018) Association between Plasma Trans-Fatty Acid Concentrations and Diabetes in a Nationally Representative Sample of US Adults. Journal of Diabetes, 10, 653-664. https://doi.org/10.1111/1753-0407.12652</mixed-citation></ref><ref id="scirp.104502-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chajès, V., Thiébaut, A.C., Rotival, M., Gauthier, E., Maillard, V., Boutron-Ruault, et al. (2008) Association between Serum Trans-Monounsaturated Fatty Acids and Breast Cancer Risk in the E3N-EPIC Study. American Journal of Epidemiology, 167, 1312-1320. https://doi.org/10.1093/aje/kwn069</mixed-citation></ref><ref id="scirp.104502-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hirko, K.A., Chai, B., Spiegelman, D., Campos, H., Farvid, M.S., Hankinson, S.E., et al. (2018) Erythrocyte Membrane Fatty Acids and Breast Cancer Risk: A Prospective Analysis in the Nurses’ Health Study II. International Journal of Cancer, 142, 1116-1129. https://doi.org/10.1002/ijc.31133</mixed-citation></ref><ref id="scirp.104502-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">WHO World Health Organization (2018) Replace Trans Fat by 2023: An Action Package to Eliminate Industrially-Produced Trans Fat from the Global Food Supply. https://www.who.int/news/item/14-05-2018-who-plan-to-eliminate-industrially-produced-trans-fatty-acids-from-global-food-supply</mixed-citation></ref><ref id="scirp.104502-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ghebreyesus, T.A. and Frieden, T.R. (2018) REPLACE: A Roadmap to Make the World Trans Fat Free by 2023. Lancet (London, England), 391, 1978-1980. https://doi.org/10.1016/S0140-6736(18)31083-3</mixed-citation></ref><ref id="scirp.104502-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mills, C.E., Hall, W.L. and Berry, S. (2017) What Are Interesterified Fats and Should We Be Worried about Them in Our Diet? Nutrition Bulletin, 42, 153-158. https://doi.org/10.1111/nbu.12264</mixed-citation></ref><ref id="scirp.104502-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Berry, S.E. (2009) Triacylglycerol Structure and Interesterification of Palmitic and Stearic Acid-Rich Fats: An Overview and Implications for Cardiovascular Disease. Nutrition Research Reviews, 22, 3-17. https://doi.org/10.1017/S0954422409369267</mixed-citation></ref><ref id="scirp.104502-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Alfieri, A., Imperlini, E., Nigro, E., Vitucci, D., Orrù, S., Daniele, A., et al. (2017) Effects of Plant Oil Interesterified Triacylglycerols on Lipemia and Human Health. International Journal of Molecular Sciences, 19, 104. https://doi.org/10.3390/ijms19010104</mixed-citation></ref><ref id="scirp.104502-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Van Rooijen, M.A. and Mensink, R.P. (2020) Palmitic Acid versus Stearic Acid: Effects of Interesterification and Intakes on Cardiometabolic Risk Markers—A Systematic Review. Nutrients, 12, 615. https://doi.org/10.3390/nu12030615</mixed-citation></ref><ref id="scirp.104502-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sundram, K., Karupaiah, T. and Hayes, K.C. (2007) Stearic Acid-Rich Interesterified Fat and Trans-Rich Fat Raise the LDL/HDL Ratio and Plasma Glucose Relative to Palm Olein in Humans. Nutrition &amp; Metabolism, 4, 3. https://doi.org/10.1186/1743-7075-4-3</mixed-citation></ref><ref id="scirp.104502-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, M. and Lokesh, B.R. (2013) Modification of Serum and Tissue Lipids in Rats Fed with Blended and Interesterified Oils Containing Groundnut Oil with Linseed Oil. Journal of Food Biochemistry, 37, 220-230. https://doi.org/10.1111/j.1745-4514.2011.00627.x</mixed-citation></ref><ref id="scirp.104502-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Reena, M.B. and Lokesh, B.R. (2012) Effect of Blending and Lipase Catalyzed Interesterification Reaction on the Cholesterol Lowering Properties of Palm Oil with Rice Bran Oil in Rats. International Journal of Food Science and Technology, 47, 203-209. https://doi.org/10.1111/j.1365-2621.2011.02827.x</mixed-citation></ref><ref id="scirp.104502-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">O’Fallon, J.V., Busboom, J.R., Nelson, M.L. and Gaskins, C.T. (2007) A Direct Method for Fatty Acid Methyl Ester Synthesis: Application to Wet Meat Tissues, Oils, and Feedstuffs. Journal of Animal Science, 85, 1511-1521. https://doi.org/10.2527/jas.2006-491</mixed-citation></ref><ref id="scirp.104502-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Vlahov, G. (1998) Regiospecific Analysis of Natural Mixtures of Triglycerides Using Quantitative 13C Nuclear Magnetic Resonance of Acyl Chain Carbonyl Carbons. Magnetic Resonance in Chemistry, 36, 359-362. https://doi.org/10.1002/(SICI)1097-458X(199805)36:5&lt;359::AID-OMR274&gt;3.0.CO;2-Z</mixed-citation></ref><ref id="scirp.104502-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Segura, N., Da Silva, R.C., Soares, F.A.S.M., Gioielli, L.A. and Jachmanián, I. (2011) Valorization of Beef Tallow by Lipase-Catalyzed Interesterification with High Oleic Sunflower Oil. JAOCS, Journal of the American Oil Chemists’ Society, 88, 1945-1954. https://doi.org/10.1007/s11746-011-1876-y</mixed-citation></ref><ref id="scirp.104502-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Gouk, S.W., Cheng, S.F., Ong, A.S. and Chuah, C.H. (2014) Stearic Acids at sn-1, 3 Positions of TAG Are More Efficient at Limiting Fat Deposition than Palmitic and Oleic Acids in C57BL/6 Mice. The British Journal of Nutrition, 111, 1174-1180. https://doi.org/10.1017/S0007114513003668</mixed-citation></ref><ref id="scirp.104502-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Bucolo, G. and David, H. (1973) Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clinical Chemistry, 19, 476-482. https://doi.org/10.1093/clinchem/19.5.476</mixed-citation></ref><ref id="scirp.104502-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W. and Fu, P.C. (1974) Enzymatic Determination of Total Serum Cholesterol. Clinical Chemistry, 20, 470-475. https://doi.org/10.1093/clinchem/20.4.470</mixed-citation></ref><ref id="scirp.104502-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Sugiuchi, H., Uji, Y., Okabe, H., Irie, T., Uekama, K., Kayahara, N. and Miyauchi, K. (1995) Direct Measurement of High-Density Lipoprotein Cholesterol in Serum with Polyethylene Glycol-Modified Enzymes and Sulfated Alpha-Cyclodextrin. Clinical Chemistry, 41, 717-723. https://doi.org/10.1093/clinchem/41.5.717</mixed-citation></ref><ref id="scirp.104502-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Trinder, P. (1969) Determination of Blood Glucose Using an Oxidase-Peroxidase System with a Non-Carcinogenic Chromogen. Journal of Clinical Pathology, 22, 158-161. https://doi.org/10.1136/jcp.22.2.158</mixed-citation></ref><ref id="scirp.104502-ref25"><label>25</label><mixed-citation publication-type="book" xlink:type="simple">Rej, R. and Horder, M. (1983) Aspartate Aminotranspherase. In: Bergmeyer, H.U., Bergmeyer, J. and Grassl, M., Eds., Methods of Enzymatic Analysis, 3rd Edition, Verlag Chemie, Weinheim, 416-433.</mixed-citation></ref><ref id="scirp.104502-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Misra, H.P. and Fridovich, I. (1972) The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase. The Journal of Biological Chemistry, 247, 3170-3175</mixed-citation></ref><ref id="scirp.104502-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Aebi, H. (1984) Catalase in Vitro. Methods in Enzymology, 105, 121-126. https://doi.org/10.1016/S0076-6879(84)05016-3</mixed-citation></ref><ref id="scirp.104502-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Flohé, L. and Günzler, W.A. (1984) Assays of Glutathione Peroxidase. Methods in Enzymology, 105, 114-121. https://doi.org/10.1016/S0076-6879(84)05015-1</mixed-citation></ref><ref id="scirp.104502-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Carlberg, I. and Mannervik, B. (1985) Glutathione Reductase. Methods in Enzymology, 113, 484-490. https://doi.org/10.1016/S0076-6879(85)13062-4</mixed-citation></ref><ref id="scirp.104502-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Beutler, E., Duron, O. and Kelly, B.M. (1963) Improved Method for the Determination of Blood Glutathione. The Journal of Laboratory and Clinical Medicine, 61, 882-888.</mixed-citation></ref><ref id="scirp.104502-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein Measurement with the Folin Phenol Reagent. The Journal of Biological Chemistry, 193, 265-275.</mixed-citation></ref><ref id="scirp.104502-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Bird, R.P. and Draper, H.H. (1984) Comparative Studies on Different Methods of Malonaldehyde Determination. Methods in Enzymology, 105, 299-305. https://doi.org/10.1016/S0076-6879(84)05038-2</mixed-citation></ref><ref id="scirp.104502-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., et al. (1990) Determination of Carbonyl Content in Oxidatively Modified Proteins. Methods in Enzymology, 186, 464-478. https://doi.org/10.1016/0076-6879(90)86141-H</mixed-citation></ref><ref id="scirp.104502-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">AOAC Association of Official Analytical Chemists (1999) Physical and Chemical Characteristics of Oils, Fats, and Waxes. US FDA, Washington DC.</mixed-citation></ref><ref id="scirp.104502-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Soares, F.A.Z.D., Silva, R.C., Silva, K.C.G., Louren&amp;#231;o, M.B., Soares, D.F. and Gioielli, L.A. (2009) Effects of Chemical Interesterification on Physicochemical Properties of Blends of Palm Stearin and Palm Olein. Food Research International, 42, 1287-1294. https://doi.org/10.1016/j.foodres.2009.03.022</mixed-citation></ref><ref id="scirp.104502-ref36"><label>36</label><mixed-citation publication-type="book" xlink:type="simple">Costales, R. and Fernández, A. (2009) Hidrogenación e Interesterificación. In: Block, J. and Barrera-Arellano, D., Eds., Temas Selectos en Aceites y Grasas, Edgard Blucher, S&amp;#227;o Paulo.</mixed-citation></ref><ref id="scirp.104502-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Mozaffarian, D. and Stampfer, M.J. (2010) Removing Industrial Trans Fat from Foods. BMJ (Clinical Research ed.), 340, c1826. https://doi.org/10.1136/bmj.c1826</mixed-citation></ref><ref id="scirp.104502-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Nishikawa, S., Sugimoto, J., Okada, M., Sakairi, T. and Takagi, S. (2012) Gene Expression in Livers of BALB/C and C57BL/6J Mice Fed a High-Fat Diet. Toxicologic Pathology, 40, 71-82. https://doi.org/10.1177/0192623311422078</mixed-citation></ref><ref id="scirp.104502-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Gouk, S.W., Cheng, S.F., Mok, J.S., Ong, A.S. and Chuah, C.H. (2013) Long-Chain SFA at the sn-1,3 Positions of TAG Reduce Body Fat Deposition in C57BL/6 Mice. The British Journal of Nutrition, 110, 1987-1995. https://doi.org/10.1017/S0007114513001475</mixed-citation></ref><ref id="scirp.104502-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Afonso, M.S., Lavrador, M.S., Koike, M.K., Cintra, D.E., Ferreira, F.D., Nunes, V.S., et al. (2016) Dietary Interesterified Fat Enriched with Palmitic Acid Induces Atherosclerosis by Impairing Macrophage Cholesterol Efflux and Eliciting Inflammation. The Journal of Nutritional Biochemistry, 32, 91-100. https://doi.org/10.1016/j.jnutbio.2016.01.005</mixed-citation></ref><ref id="scirp.104502-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Lavrador, M., Afonso, M.S., Cintra, D.E., Koike, M., Nunes, V.S., Demasi, M., et al. (2019) Interesterified Fats Induce Deleterious Effects on Adipose Tissue and Liver in LDLr-KO Mice. Nutrients, 11, 466. https://doi.org/10.3390/nu11020466</mixed-citation></ref><ref id="scirp.104502-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Magri, T.P., Fernandes, F.S., Souza, A.S., Langhi, L.G., Barboza, T., Misan, V., Mucci, et al. (2015) Interesterified Fat or Palm Oil as Substitutes for Partially Hydrogenated Fat in Maternal Diet Can Predispose Obesity in Adult Male Offspring. Clinical Nutrition (Edinburgh, Scotland), 34, 904-910. https://doi.org/10.1016/j.clnu.2014.09.014</mixed-citation></ref><ref id="scirp.104502-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">De Velasco, P., Fernandes, F., Mucci, D., Santos, R., Magri, T., Misan, V. and Tavares do Carmo, M.d.G. (2015) Interesterified Fat or Palm Oil as Substitutes for Trans Fat in Maternal Diet Can Predispose Obesity and Inflammation in Adult Male Offspring. The FASEB Journal, 29, 754.</mixed-citation></ref><ref id="scirp.104502-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Bispo, K.P., de Oliveira Rodrigues, L., da Silva Soares de Souza, é., Mucci, D., Tavares do Carmo, M.d., de Albuquerque, K.T. and de Carvalho Sardinha, F.L. (2015) Trans and Interesterified Fat and Palm Oil during the Pregnancy and Lactation Period Inhibit the Central Anorexigenic Action of Insulin in Adult Male Rat Offspring. The Journal of Physiological Sciences, 65, 131-138. https://doi.org/10.1007/s12576-014-0351-6</mixed-citation></ref><ref id="scirp.104502-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Ponnampalam, E.N., Lewandowski, P., Nesaratnam, K., Dunshea, F.R. and Gill, H. (2011) Differential Effects of Natural Palm Oil, Chemically- and Enzymatically-Modified Palm Oil on Weight Gain, Blood Lipid Metabolites and Fat Deposition in a Pediatric Pig Model. Nutrition Journal, 10, 53. https://doi.org/10.1186/1475-2891-10-53</mixed-citation></ref><ref id="scirp.104502-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Reena, M.B. and Lokesh, B.R. (2007) Hypolipidemic Effect of Oils with Balanced Amounts of Fatty Acids Obtained by Blending and Interesterification of Coconut Oil with Rice Bran Oil or Sesame Oil. Journal of Agricultural and Food Chemistry, 55, 10461-10469. https://doi.org/10.1021/jf0718042</mixed-citation></ref><ref id="scirp.104502-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Nagaraju, A. and Lokesh, B.R. (2007) Interesterified Coconut Oil Blends with Groundnut Oil or Olive Oil Exhibit Greater Hypocholesterolemic Effects Compared with Their Respective Physical Blends in Rats. Nutrition Research, 27, 580-586. https://doi.org/10.1016/j.nutres.2007.06.007</mixed-citation></ref><ref id="scirp.104502-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Reena, M.B., Gowda, L.R. and Lokesh, B.R. (2011) Enhanced Hypocholesterolemic Effects of Interesterified Oils Are Mediated by Upregulating LDL Receptor and Cholesterol 7-α-Hydroxylase Gene Expression in Rats. The Journal of Nutrition, 141, 24-30. https://doi.org/10.3945/jn.110.127027</mixed-citation></ref><ref id="scirp.104502-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Blaha, M.J., Blumenthal, R.S., Brinton, E.A., Jacobson, T.A. and National Lipid Association Taskforce on Non-HDL Cholesterol (2008) The Importance of non-HDL Cholesterol Reporting in Lipid Management. Journal of Clinical Lipidology, 2, 267-273. https://doi.org/10.1016/j.jacl.2008.06.013</mixed-citation></ref><ref id="scirp.104502-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Mensink, R.P., Zock, P.L., Kester, A.D. and Katan, M.B. (2003) Effects of Dietary Fatty Acids and Carbohydrates on the Ratio of Serum Total to HDL Cholesterol and on Serum Lipids and Apolipoproteins: A Meta-Analysis of 60 Controlled Trials. The American Journal of Clinical Nutrition, 77, 1146-1155. https://doi.org/10.1093/ajcn/77.5.1146</mixed-citation></ref><ref id="scirp.104502-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Sun, Y., Neelakantan, N., Wu, Y., Lote-Oke, R., Pan, A. and van Dam, R.M. (2015) Palm Oil Consumption Increases LDL Cholesterol Compared with Vegetable Oils Low in Saturated Fat in a Meta-Analysis of Clinical Trials. The Journal of Nutrition, 145, 1549-1558. https://doi.org/10.3945/jn.115.210575</mixed-citation></ref><ref id="scirp.104502-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez-Leyva, D., Dupasquier, C.M., McCullough, R. and Pierce, G.N. (2010) The Cardiovascular Effects of Flaxseed and Its Omega-3 Fatty Acid, Alpha-Linolenic Acid. The Canadian Journal of Cardiology, 26, 489-496. https://doi.org/10.1016/S0828-282X(10)70455-4</mixed-citation></ref><ref id="scirp.104502-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Filippou, A., Teng, K.-T., Berry, S.E. and Sanders, T.A.B. (2014) Palmitic Acid in the sn-2 Position of Dietary Triacylglycerols Does Not Affect Insulin Secretion or Glucose Homeostasis in Healthy Men and Women. European Journal of Clinical Nutrition, 68, 1036-1041. https://doi.org/10.1038/ejcn.2014.141</mixed-citation></ref><ref id="scirp.104502-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Miyamoto, J.é., Ferraz, A.C.G., Portovedo, M., Reginato, A., Stahl, M.A., Ignacio-Souza, L.M., et al (2018) Interesterified Soybean Oil Promotes Weight Gain, Impaired Glucose Tolerance and Increased Liver Cellular Stress Markers. The Journal of Nutritional Biochemistry, 59, 153-159. https://doi.org/10.1016/j.jnutbio.2018.05.014</mixed-citation></ref><ref id="scirp.104502-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Masarone, M., Rosato, V., Dallio, M., Gravina, A.G., Aglitti, A., Loguercio, C., et al (2018) Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 9547613. https://doi.org/10.1155/2018/9547613</mixed-citation></ref><ref id="scirp.104502-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Monguchi, T., Hara, T., Hasokawa, M., Nakajima, H., Mori, K., Toh, R., Irino, Y., Ishida, T., Hirata, K.I. and Shinohara, M. (2017) Excessive Intake of Trans Fatty Acid Accelerates Atherosclerosis through Promoting Inflammation and Oxidative Stress in a Mouse Model of Hyperlipidemia. Journal of Cardiology, 70, 121-127. https://doi.org/10.1016/j.jjcc.2016.12.012</mixed-citation></ref><ref id="scirp.104502-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Dhibi, M., Brahmi, F., Mnari, A., Houas, Z., Chargui, I., Bchir, L., Gazzah, N., Alsaif, M.A. and Hammami, M. (2011) The Intake of High Fat Diet with Different Trans Fatty Acid Levels Differentially Induces Oxidative Stress and Non Alcoholic Fatty Liver Disease (NAFLD) in Rats. Nutrition and Metabolism, 8, 65. https://doi.org/10.1186/1743-7075-8-65</mixed-citation></ref><ref id="scirp.104502-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y., Yang, X., Shi, H., Dong, L. and Bai, J. (2011) Effect of α-Linolenic Acid on Endoplasmic Reticulum Stress-Mediated Apoptosis of Palmitic Acid Lipotoxicity in Primary Rat Hepatocytes. Lipids in Health and Disease, 10, 122. https://doi.org/10.1186/1476-511X-10-122</mixed-citation></ref><ref id="scirp.104502-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Guo, W., Wong, S., Xie, W., Lei, T. and Luo, Z. (2007) Palmitate Modulates Intracellular Signaling, Induces Endoplasmic Reticulum Stress, and Causes Apoptosis in Mouse 3T3-L1 and Rat Primary Preadipocytes. American Journal of Physiology. Endocrinology and Metabolism, 293, E576-E586. https://doi.org/10.1152/ajpendo.00523.2006</mixed-citation></ref><ref id="scirp.104502-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Yao, J.K., Leonard, S. and Reddy, R. (2006) Altered Glutathione Redox State in Schizophrenia. Disease Markers, 22, 83-93. https://doi.org/10.1155/2006/248387</mixed-citation></ref><ref id="scirp.104502-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Pettersson, U.S., Waldén, T.B., Carlsson, P.O., Jansson, L. and Phillipson, M. (2012) Female Mice Are Protected against High-Fat Diet Induced Metabolic Syndrome and Increase the Regulatory T Cell Population in Adipose Tissue. PLoS One, 7, e46057. https://doi.org/10.1371/journal.pone.0046057</mixed-citation></ref></ref-list></back></article>